• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测成人Xp11.2易位性肾细胞癌的新风险评分系统。

A new risk-scoring system to predict Xp11.2 translocation renal cell carcinoma in adults.

作者信息

Shi Qiancheng, Liu Ning, Zhu Yiqi, Qu Feng, Xu Linfeng, Li Xiaogong, Zhang Gutian, Guo Hongqian, Li Dongmei, Gan Weidong

机构信息

Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.

Immunology and Reproduction Biology Laboratory & State Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Nanjing, Jiangsu, China.

出版信息

J Int Med Res. 2021 Mar;49(3):300060521997661. doi: 10.1177/0300060521997661.

DOI:10.1177/0300060521997661
PMID:33752453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7995454/
Abstract

OBJECTIVE

The objective was to derive and validate a practical scoring system for preoperative diagnosis of Xp11.2 translocation renal cell carcinoma (RCC) in adults.

METHODS

Epidemiology, symptomatology, and imaging methods were correlated between patients with common RCC and those with Xp11.2 translocation RCC using a derivation study (N = 6352) and a validation study (N = 127). Univariate analysis of risk factors was performed to derive a scoring system to predict the occurrence of Xp11.2 translocation RCC in adults. The Hosmer-Lemeshow goodness-of-fit test and receiver operating characteristic (ROC) curve were used to validate the scoring system.

RESULTS

Based on odd ratios, three low-risk factors (sex, gross haematuria, and intratumoural calcification) and three high-risk factors (age, unenhanced computed tomography density, and enhancement pattern) were given weighted scores of 1 and 2, respectively. Patients who scored 3 to 5 points underwent an additional magnetic resonance imaging examination. The final scoring system had a sensitivity of 81.0% and a specificity of 98.0%.

CONCLUSION

We established a practical scoring system for the preoperative diagnosis of Xp11.2 translocation RCC in adults, which can be optimised through further clinical findings in the future.

摘要

目的

旨在推导并验证一种用于成人Xp11.2易位性肾细胞癌(RCC)术前诊断的实用评分系统。

方法

利用一项推导研究(N = 6352)和一项验证研究(N = 127),对常见RCC患者与Xp11.2易位性RCC患者之间的流行病学、症状学及影像学方法进行相关性分析。对风险因素进行单因素分析,以推导一个预测成人Xp11.2易位性RCC发生的评分系统。采用Hosmer-Lemeshow拟合优度检验和受试者工作特征(ROC)曲线对该评分系统进行验证。

结果

基于比值比,三个低风险因素(性别、肉眼血尿和肿瘤内钙化)和三个高风险因素(年龄、未增强计算机断层扫描密度和强化模式)分别给予加权分数1分和2分。得分为3至5分的患者需额外进行磁共振成像检查。最终的评分系统敏感性为81.0%,特异性为98.0%。

结论

我们建立了一种用于成人Xp11.2易位性RCC术前诊断的实用评分系统,未来可通过进一步的临床发现对其进行优化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9209/7995454/e8682c96d3f8/10.1177_0300060521997661-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9209/7995454/33f35e0221de/10.1177_0300060521997661-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9209/7995454/e8682c96d3f8/10.1177_0300060521997661-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9209/7995454/33f35e0221de/10.1177_0300060521997661-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9209/7995454/e8682c96d3f8/10.1177_0300060521997661-fig2.jpg

相似文献

1
A new risk-scoring system to predict Xp11.2 translocation renal cell carcinoma in adults.一种用于预测成人Xp11.2易位性肾细胞癌的新风险评分系统。
J Int Med Res. 2021 Mar;49(3):300060521997661. doi: 10.1177/0300060521997661.
2
MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma.Xp11.2 易位/TFE3 基因融合相关性肾细胞癌和乳头状肾细胞癌的 MDCT 表现
AJR Am J Roentgenol. 2015 Mar;204(3):542-9. doi: 10.2214/AJR.14.12950.
3
The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma.与XP11.2易位/TFE基因融合相关的肾癌及集合管癌的多层螺旋CT表现
Acta Radiol. 2013 Apr 1;54(3):355-62. doi: 10.1258/ar.2012.120255. Epub 2013 Feb 27.
4
Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.Xp11.2 易位/TFE3 基因融合相关性成人肾细胞癌的超声造影表现:与透明细胞肾细胞癌和乳头状肾细胞癌的比较。
Cancer Imaging. 2019 Dec 31;20(1):1. doi: 10.1186/s40644-019-0268-7.
5
Renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion: imaging findings in 21 patients.与Xp11.2易位/TFE基因融合相关的肾细胞癌:21例患者的影像学表现
Eur Radiol. 2017 Feb;27(2):543-552. doi: 10.1007/s00330-016-4421-4. Epub 2016 Jun 2.
6
Dynamic Computed Tomographic Features of Adult Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene Fusions: Comparison With Clear Cell Renal Cell Carcinoma.与Xp11.2易位/TFE3基因融合相关的成人肾细胞癌的动态计算机断层扫描特征:与透明细胞肾细胞癌的比较
J Comput Assist Tomogr. 2015 Sep-Oct;39(5):730-6. doi: 10.1097/RCT.0000000000000263.
7
The incidence of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in Saudi adult patients with renal cancer: a retrospective tissue microarray analysis.沙特成年肾癌患者中与Xp11.2易位/TFE3基因融合相关的肾细胞癌发病率:一项回顾性组织芯片分析
Pol J Pathol. 2018;69(4):376-383. doi: 10.5114/pjp.2018.81697.
8
Bilateral Xp11.2 translocation renal cell carcinoma: a case report.Xp11.2 易位性双侧肾细胞癌 1 例报告
BMC Urol. 2018 Nov 20;18(1):106. doi: 10.1186/s12894-018-0419-3.
9
Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients.术前中性粒细胞与淋巴细胞比值可预测Xp11.2易位/TFE3肾细胞癌患者的手术结果。
BMC Urol. 2018 Jun 11;18(1):60. doi: 10.1186/s12894-018-0374-z.
10
[Differential diagnosis between renal cell carcinoma associated with XP11.2 translocation/TFE gene fusion and papillary renal cell carcinoma based on CT and MRI findings].基于CT和MRI表现的XP11.2易位/TFE基因融合相关性肾细胞癌与乳头状肾细胞癌的鉴别诊断
Zhonghua Yi Xue Za Zhi. 2014 May 20;94(19):1470-2.

引用本文的文献

1
A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic -rearranged renal cell carcinoma:a case report.新辅助治疗与手术切除联合用于转移性重排肾细胞癌的安全有效治疗方案:一例报告
Front Oncol. 2023 Oct 23;13:1252282. doi: 10.3389/fonc.2023.1252282. eCollection 2023.

本文引用的文献

1
Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China.成人 Xp11.2 易位肾细胞癌临床 T1 期行保留肾单位手术:中国多中心研究。
Ann Surg Oncol. 2021 Feb;28(2):1238-1246. doi: 10.1245/s10434-020-08813-y. Epub 2020 Jul 6.
2
Comparative Clinicopathologic Characteristics and Outcomes of Paediatric and Adult Xp11 Translocation Renal Cell Carcinomas: a Retrospective Multicentre Study in China.中国多中心回顾性研究:儿童与成人 Xp11 易位性肾细胞癌的临床病理特征与结局比较。
Sci Rep. 2020 Feb 10;10(1):2249. doi: 10.1038/s41598-020-59162-5.
3
Cancer statistics, 2020.
癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
4
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge.MiT家族易位性肾细胞癌:从早期描述到当前认知
Cancers (Basel). 2019 Aug 3;11(8):1110. doi: 10.3390/cancers11081110.
5
Identification of endometrial cancers and atypical hyperplasia: Development and validation of a simplified system for ultrasound scoring of endometrial pattern.子宫内膜癌和不典型增生的识别:超声子宫内膜形态评分简化系统的开发和验证。
Maturitas. 2019 May;123:15-24. doi: 10.1016/j.maturitas.2019.01.017. Epub 2019 Feb 1.
6
Altered X-chromosome inactivation in T cells may promote sex-biased autoimmune diseases.T 细胞中 X 染色体失活的改变可能促进性别偏向性自身免疫性疾病。
JCI Insight. 2019 Apr 4;4(7). doi: 10.1172/jci.insight.126751.
7
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.欧洲泌尿外科学会肾癌指南:2019 年更新版。
Eur Urol. 2019 May;75(5):799-810. doi: 10.1016/j.eururo.2019.02.011. Epub 2019 Feb 23.
8
Imaging in Suspected Renal-Cell Carcinoma: Systematic Review.疑似肾细胞癌的影像学检查:系统综述。
Clin Genitourin Cancer. 2019 Apr;17(2):e345-e355. doi: 10.1016/j.clgc.2018.07.024. Epub 2018 Aug 11.
9
Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching Analysis.Xp11.2 易位性肾细胞癌的临床病理特征和预后:多中心、倾向评分匹配分析。
Clin Genitourin Cancer. 2017 Oct;15(5):e819-e825. doi: 10.1016/j.clgc.2017.04.015. Epub 2017 Apr 26.
10
Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies.XP11.2易位/TFE3基因融合性肾细胞癌的临床特征:一项观察性研究的系统评价和荟萃分析
BMC Urol. 2016 Jul 11;16(1):40. doi: 10.1186/s12894-016-0154-6.